A review on rett syndrome: A debilitating neurodevelopmental disorder Narava Sri Satya Sai1,*, Kucherlapati Sowmya1, Mugada Vinod Kumar1, Yarguntla Srinivasa Rao2 1Department of Pharmacy Practice, Vignan Institute of Pharmaceutical Technology, Duvvada, Andhra Pradesh, India 2Department of Pharmaceutics, Vignan Institute of Pharmaceutical Technology, Duvvada, Andhra Pradesh, India *Corresponding Author E-mail: satyasaisri2016@gmail.com
Online Published on 30 January, 2024. Abstract Rett syndrome is a neurodevelopmental disorder primarily affecting females, characterised by slowed growth, developmental regression, loss of fine motor skills, communication difficulties, and stereotypical hand movements. It is strongly associated with mutations in the MECP2 gene, while other variations have been linked to FOXG1 and CDKL5 mutations. This review provides an in-depth understanding of Rett syndrome, including its causes, symptoms, and available treatments. The epidemiology of Rett syndrome indicates a varying prevalence across different regions. Males with Rett syndrome, though rare, have been reported. The aetiology of Rett syndrome involves MECP2 mutations that lead to functional loss, affecting synapse development and maintenance. Mitochondrial dysfunction and oxidative stress have also been implicated in the disorder. Neuropathological findings reveal specific abnormalities in various brain regions. The symptoms of Rett syndrome include slowed head growth, abnormal gait, loss of intentional hand movements, breathing difficulties, and loss of speech. Complications such as metabolic issues, epilepsy, scoliosis, and gastrointestinal dysfunction are common. The diagnosis relies on clinical criteria and genetic testing for MECP2 mutations. Treatment for Rett syndrome is symptomatic and includes individualised rehabilitation therapies such as physical therapy, applied behaviour analysis, environmental enrichment, hydrotherapy, and music therapy. The review emphasises the importance of early intervention and family involvement in rehabilitation programmes. Top Keywords Cyclin-dependent kinase-like 5, Forkhead box protein G1, Methyl-CpG-binding protein 2 gene, Rett syndrome. Top |